Donglan Cai

Donglan (Diana) Cai is an experienced professional in regulatory affairs, holding positions such as Senior Director of Regulatory Affairs at I-Mab Biopharma and Director of Regulatory Affairs at SinoMab BioScience Ltd. Previous roles include Associate Director of Regulatory Affairs Strategy at Taiho Oncology, Inc., and Director of Regulatory Affairs at Klus Pharma Inc. Additionally, Donglan (Diana) Cai served as Manager of Regulatory Affairs at PuraCap Pharmaceuticals, demonstrating a robust background in the field across multiple organizations.